Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-15
1995-10-31
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140, A61K 31535
Patent
active
054629624
ABSTRACT:
This invention provides 6-substituted-4-(amino or substituted amino)tetrahydrobenz[c,d]indole serotonin agonists useful in treating a variety of conditions associated with serotonin function.
REFERENCES:
patent: 4110339 (1978-08-01), Bach et al.
patent: 4576959 (1986-03-01), Flaugh
patent: 4640921 (1987-02-01), Othmer et al.
patent: 4745126 (1988-05-01), Leander
patent: 4983622 (1991-01-01), Flaugh
patent: 5021438 (1991-06-01), Junge et al.
patent: 5204340 (1993-04-01), Flaugh et al.
patent: 5229409 (1993-07-01), Flaugh et al.
patent: 5229410 (1993-07-01), Flaugh et al.
patent: 5302612 (1994-04-01), Flaugh et al.
Kostowski et al., Pharmacol. Toxicol., 71, pp. 24-30 (1992).
Fuller, Frontiers in Neuroendocrinology, 13(3), pp. 250-270 (1992).
Flaugh et al., J. Med. Chem., 31, 1746-1753 (1988).
Tetrahedron Letters 21, 4061 (1980).
Kornfeld et al., J.A.C.S., 78, 3087 (1956).
Morrison and Boyd, Chapter 22, Org. Chem., 3rd Ed. (1973).
Schoenberg and Heck, Journal of Organic Chemistry, 39, 3327 (1974).
Schoenberg, Bartoletti and Heck, Journal of Organic Chemistry, 39, 3118 (1974).
T. W. Greene, Chapter 7, Protective Groups in Org. Synth. (1981).
J. W. Barton, Chapter 2, Protective Groups in Org. Chem. (1981).
Leanna et al., Tetrahedron Letters 30, 3935 (1989).
Wong et al., J. Neural Transmission, 64, 251 (1985).
The Merck Manual Rahway N.J., Merck and Company, 1657-1667 (1987).
Mathes et al., Pharmacology, Biochem and Behavior 36, 63-68 (1990).
Glaser et al., Brain 5-HT.sub.1A Receptors, Chapter 9, 106-119 (1987).
Ahlenius et al., Brain 5-HT.sub.1A Receptors, Chapter 16, 185-198 (1987).
Othmer et al., J. Clin. Psychiatry, 48, 201-203 (1987).
Flaugh Michael E.
Foreman Mark M.
Benjamin Roger S.
Boone David E.
Dees Jos,e G.
Eli Lilly and Company
Frazier B.
LandOfFree
Tetrahydrobenz[c,d]indole serotonin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydrobenz[c,d]indole serotonin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrobenz[c,d]indole serotonin agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1772700